M. Lopezhoyos et al., REGULATION OF B-CELL APOPTOSIS BY BCL-2 AND BCL-X-L AND ITS ROLE IN THE DEVELOPMENT OF AUTOIMMUNE-DISEASES (REVIEW), INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 1(2), 1998, pp. 475-483
Cell death is a common event during B cell development. The demise of
developing B cells is a regulated process that serves to select cell p
opulations bearing functional receptors and to remove cells that are n
o longer needed or potentially autoreactive. Bcl-2 and Bcl-X-L, two me
mbers of the bcl-2 gene family of programmed cell death regulators wit
h anti-apoptotic activity, are expressed in a highly regulated pattern
during B cell maturation. Overexpression of Bcl-2 in developing B cel
ls of transgenic mice, in the presence of T cell dependent costimulato
ry signals, results in the generation of a modified B cell repertoire
and in the production of pathogenic autoantibodies. While disregulatio
n of programmed cell death in B cells may cause autoimmune manifestati
ons in mice, the involvement of such alterations in the pathogenesis o
f autoimmune diseases in humans merits further investigation.